Schmerzmedizin 2 / 2019

7. Headache Classification Committee of The International Headache Society. The International Classification of Headache Disorders 3rd edition (beta version). Cephalalgia 2013;33:629-808 8. Stolte B, Holle D, Naegel S et al. Vestibular migraine. Cephalalgia 2015;35:262-70 9. Millen SJ, Schnurr CM, Schnurr BB. Vestibular migraine: perspectives of otology versus neurology. Otol Neurotol 2011;32:330-7 10. Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol 1999;246:883-92 11. Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache 1992;32:300-4 12. Johnson GD. Medical management of migraine-related dizziness and vertigo. Laryngoscope 1998;108:1-28 13. Neuhauser H, Leopold M, von Brevern M et al. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 2001;56:436-41 14. Kayan A, Hood JD. Neuro-otological manifestations of migraine. Brain 1984;107:1123-42 15. Neuhauser HK, Radtke A, von Brevern M et al. Migrainous vertigo: prevalence and impact on quality of life. Neurology 2006;67:1028-33 16. Slater R. Benign recurrent vertigo. J Neurol Neurosurg Psychiatry 1979;42:363-7 17. Moretti G, Manzoni GC, Caffarra P et al. „Benign recurrent vertigo“ and its connection with migraine. Headache 1980;20:344-6 18. Waterston J. Chronic migrainous vertigo. J Clin Neurosci 2004;11:384-8 19. Drummond PD. Triggers of motion sickness in migraine sufferers. Headache 2005;45:653-6 20. Yoon MS, Katsarava Z, Obermann M et al. Prevalence of primary headaches in Germany: results of the German Headache Consortium Study. J Headache Pain 2012;13:215-23 21. Calhoun AH, Ford S, Pruitt AP et al. The point prevalence of dizziness or vertigo in migraine--and factors that influence presentation. Headache 2011;51:1388-92 22. Cass SP, Furman JM, Ankerstjerne K et al. Migraine-related vestibulo­ pathy. Ann Otol Rhinol Laryngol 1997;106:182-9 23. Oh AK, Lee H, Jen JC et al. Familial benign recurrent vertigo. Am J Med Genet 2001;100:287-91 24. Kuritzky A, Toglia UJ, Thomas D. Vestibular function in migraine. Headache 1981;21:110-2 25. Cha YH, Baloh RW. Migraine associated vertigo. J Clin Neurol 2007;3:121-6 26. Akdal G, Ozge A, Ergor G. The prevalence of vestibular symptoms in migraine or tension-type headache. J Vestib Res 2013;23:101-6 27. Lempert T, Neuhauser H, Daroff RB. Vertigo as a symptom of migraine. Ann N Y Acad Sci 2009;1164:242-51 28. Neuhauser H, Radtke A, von Brevern M et al. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology 2003;60:882-3 29. Furman JM, Marcus DA, Balaban CD. Rizatriptan reduces vestibular-induced motion sickness in migraineurs. J Headache Pain 2011;12:81-8 30. Baier B, Winkenwerder E, Dieterich M. „Vestibular migraine“: effects of prophylactic therapy with various drugs. A retrospective study. J Neurol 2009;256:436-42 31. Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol 1997;18:350-4 32. Maione A. Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope 2006;116:1782-6 33. Gordon CR, Kuritzky A, Doweck I et al. Vestibulo-ocular reflex in migraine patients: the effect of sodium valproate. Headache 1993;33:129-32 34. Bisdorff AR. Treatment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Grand Duche Luxemb 2004;(2):103-8 35. Lampl C, Katsarava Z, Diener HC et al. Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 2005;76:1730-2 36. Taghdiri F, Togha M, Razeghi Jahromi S et al. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. SpringerPlus 2014;3:231 37. Lepcha A, Amalanathan S, Augustine AM et al. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol 2014;271:2931-6 38. de Bock GH, Eelhart J, van Marwijk HW et al. A postmarketing study of flunarizine in migraine and vertigo. Pharm World Sci 1997;19:269-74 39. Verspeelt J, De Locht P, Amery WK. Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine. Eur J Clin Pharmacol 1996;51:15-22 40. Van Ombergen A, Van Rompaey V, Van de Heyning P et al. Vestibular migraine in an otolaryngology clinic: prevalence, associated symptoms, and prophylactic medication effectiveness. Otol Neurotol 2015;36:133-8 41. Salviz M, Yuce T, Acar H et al. Propranolol and venlafaxine for vestibular migraine prophylaxis: A randomized controlled trial. Laryngoscope 2016;126:169-74 42. Vitkovic J, Winoto A, Rance G et al. Vestibular rehabilitation outcomes in patients with and without vestibular migraine. J Neurol 2013;260:3039-48 43. Mikulec AA, Faraji F, Kinsella LJ. Evaluation of the efficacy of caffeine cessation, nortriptyline, and topiramate therapy in vestibular migraine and complex dizziness of unknown etiology. Am J Otolaryngol 2012;33:121-7 44. Dodick DW, Turkel CC, DeGryse RE et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010;50:921-36 Schmerzmedizin 2019; 35 (2) 27

RkJQdWJsaXNoZXIy MjQxNTg=